Laboratorios Farmacéuticos Rovi SA
Stock Details
Is it expensive?
Market Cap
3.07B
Trailing P/E Ratio
25.02
Forward P/E Ratio
16.50
PEG Ratio
-0.28
3.47B
17.73
Price-to-Sales (TTM)
4.06
4.55
12.99
Is it profitable?
743.48M
Net Profit Margin (TTM)
18.89%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
2.36
22.33%
Is it growing?
9.70%
82.50%
Is it risky?
0.30
18.04
121.82M
3.13
Who owns it?
19.49%
68.03%
0.00%
51.15M
16.30M
Does it pay?
6.21%
39.58%
Jul 14, 2025
--
How much cash?
98.60M
187.08M
82.30M
1.93
- Price (EOD)
- 59.05
- Percent Change
- -0.75 (1.25%)
- Previous Close
- 59.80
- Open
- 60.35
- Low
- 58.75
- High
- 60.35
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
€59.05
From 52W Low
+16.01%
From 52W High
-31.89%
Today
-1.25%
1Y Change
+13.23%
6M
€58.70
3M
€84.60
1M
€80.70
Today
€59.05
From 52W Low
+16.01%
From 52W High
-31.89%
Today
-1.25%
1Y Change
+13.23%
6M
€58.70
3M
€84.60
1M
€80.70
Today
€59.05
Below Average
within its 1-year price range
€59.05
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-26.8%
3M
-30.2%
6M
+0.6%
1Y
+13.2%
Rate of Change (ROC)
Accelerating
Price is falling 8.9x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Below Average
Fewer shares than usual are trading today. Low volume moves are less reliable. Price can drift without real conviction behind it. As reflected in the Relative Volume (RVOL) below.
- Name
- Laboratorios Farmacéuticos Rovi SA
- Founded
- 1946
- CEO
- Juan Lopez-Belmonte Encina
- Employees
- 1,950
- Fiscal Year End
- Dec 31, 2025
- Address
Calle José Isbert, 2
Pozuelo de Alarcón
MI
28223
Spain
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.rovi.es
Indicators
Operating Cash Flow
187.08M
Net Income
140.44M
Real Earnings
1.33
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
IBEX 35Index IBEX 35 - IBEX35 |
Indicators
Operating Cash Flow
187.08M
Net Income
140.44M
Real Earnings
1.33
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
3.07B
Trailing P/E Ratio
25.02
Forward P/E Ratio
16.50
PEG Ratio
-0.28
3.47B
17.73
Price-to-Sales (TTM)
4.06
4.55
12.99
Is it profitable?
743.48M
Net Profit Margin (TTM)
18.89%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
2.36
22.33%
Is it growing?
9.70%
82.50%
Is it risky?
0.30
18.04
121.82M
3.13
Who owns it?
19.49%
68.03%
0.00%
51.15M
16.30M
Does it pay?
6.21%
39.58%
Jul 14, 2025
--
How much cash?
98.60M
187.08M
82.30M
1.93
- Price (EOD)
- 59.05
- Percent Change
- -0.75 (1.25%)
- Previous Close
- 59.80
- Open
- 60.35
- Low
- 58.75
- High
- 60.35
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
€59.05
From 52W Low
+16.01%
From 52W High
-31.89%
Today
-1.25%
1Y Change
+13.23%
6M
€58.70
3M
€84.60
1M
€80.70
Today
€59.05
From 52W Low
+16.01%
From 52W High
-31.89%
Today
-1.25%
1Y Change
+13.23%
6M
€58.70
3M
€84.60
1M
€80.70
Today
€59.05
Below Average
within its 1-year price range
€59.05
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
-26.8%
3M
-30.2%
6M
+0.6%
1Y
+13.2%
Rate of Change (ROC)
Accelerating
Price is falling 8.9x faster than usual. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Below Average
Fewer shares than usual are trading today. Low volume moves are less reliable. Price can drift without real conviction behind it. As reflected in the Relative Volume (RVOL) below.
- Name
- Laboratorios Farmacéuticos Rovi SA
- Founded
- 1946
- CEO
- Juan Lopez-Belmonte Encina
- Employees
- 1,950
- Fiscal Year End
- Dec 31, 2025
- Address
Calle José Isbert, 2
Pozuelo de Alarcón
MI
28223
Spain
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Pharmaceuticals
- Website
- www.rovi.es
Related Heatmaps
IBEX 35Index IBEX 35 - IBEX35 |